Search research articles
Contact Us
Filters
Showing results (261-270 of 441) with videos related to
Page
of 45
Sort By:
The Journal of Pediatrics
|
May 1, 1978
Serologic and clinical response of children with sickle cell disease to bivalent influenza A split virus vaccine
E Steinberg, G D Overturf, B Portnoy, et al.
Journal of Natural Products
|
January 1, 1991
Limonoid antifeedants from seed of Sandoricum koetjape
R G Powell, K L Mikolajczak, B W Zilkowski, et al.
The Tokai Journal of Experimental and Clinical Medicine
|
January 1, 1988
Relationship of pertussis immunization to the onset of epilepsy, febrile convulsions and central nervous system infections: a retrospective epidemiologic study
V Jacobson, C Nielsen, D Buch, et al.
The Pediatric Infectious Disease Journal
|
December 1, 1987
Recurrent Bipolaris sinusitis following surgical and antifungal therapy
L Frenkel, T L Kuhls, K Nitta, et al.
The Pediatric Infectious Disease Journal
|
May 1, 1995
Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis
K Lewis, M A Saubolle, F C Tenover, et al.
American Journal of Diseases of Children (1960)
|
July 1, 1991
DTP immunization and susceptibility to infectious diseases. Is there a relationship?
M Davidson, G W Letson, J I Ward, et al.
American Journal of Diseases of Children (1960)
|
September 1, 1986
A double-blind study comparing an acellular pertussis-component DTP vaccine with a whole-cell pertussis-component DTP vaccine in 18-month-old children
K Lewis, J D Cherry, H J Holroyd, et al.
Developments in Biological Standardization
|
January 1, 1997
Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group
M A Uberall, K Stehr, J D Cherry, et al.
Developments in Biological Standardization
|
January 1, 1997
Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group
S Schmitt-Grohé, K Stehr, J D Cherry, et al.
European Journal of Pediatrics
|
April 8, 2010
Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children
Marie-Louise von Linstow, Peter Lotko Pontoppidan, Carl-Heinz Wirsing von König, et al.
Page
of 45
Search research articles
Search
Showing results (261-270 of 441) with videos related to
Sort By:
Page
of 45
The Journal of Pediatrics
|
May 1, 1978
Serologic and clinical response of children with sickle cell disease to bivalent influenza A split virus vaccine
E Steinberg, G D Overturf, B Portnoy, et al.
Journal of Natural Products
|
January 1, 1991
Limonoid antifeedants from seed of Sandoricum koetjape
R G Powell, K L Mikolajczak, B W Zilkowski, et al.
The Tokai Journal of Experimental and Clinical Medicine
|
January 1, 1988
Relationship of pertussis immunization to the onset of epilepsy, febrile convulsions and central nervous system infections: a retrospective epidemiologic study
V Jacobson, C Nielsen, D Buch, et al.
The Pediatric Infectious Disease Journal
|
December 1, 1987
Recurrent Bipolaris sinusitis following surgical and antifungal therapy
L Frenkel, T L Kuhls, K Nitta, et al.
The Pediatric Infectious Disease Journal
|
May 1, 1995
Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis
K Lewis, M A Saubolle, F C Tenover, et al.
American Journal of Diseases of Children (1960)
|
July 1, 1991
DTP immunization and susceptibility to infectious diseases. Is there a relationship?
M Davidson, G W Letson, J I Ward, et al.
American Journal of Diseases of Children (1960)
|
September 1, 1986
A double-blind study comparing an acellular pertussis-component DTP vaccine with a whole-cell pertussis-component DTP vaccine in 18-month-old children
K Lewis, J D Cherry, H J Holroyd, et al.
Developments in Biological Standardization
|
January 1, 1997
Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group
M A Uberall, K Stehr, J D Cherry, et al.
Developments in Biological Standardization
|
January 1, 1997
Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group
S Schmitt-Grohé, K Stehr, J D Cherry, et al.
European Journal of Pediatrics
|
April 8, 2010
Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children
Marie-Louise von Linstow, Peter Lotko Pontoppidan, Carl-Heinz Wirsing von König, et al.
Page
of 45